News for Healthier Living

Engineering Natural Killer Cells May Reshape the Future of Cancer Immunotherapy

Chimeric antigen receptor natural killer (CAR-NK) cell therapy is emerging as a promising next-generation immunotherapy with the potential to overcome key limitations of current chimeric antigen receptor T-cell therapy (CAR-T) treatments.

January 5, 2026


January 6 2026

January 5 2026

January 4 2026

January 3 2026

January 2 2026

January 1 2026

December 31 2025

December 30 2025

December 29 2025

December 28 2025

December 27 2025

December 26 2025

December 24 2025